This inventor holds 1 USPTO granted patent. Top assignee: Gloriana Therapeutics Sarl. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Ping Jin from Southborough, MA
Introduction
Ping Jin is an accomplished inventor based in Southborough, Massachusetts, whose work has led to significant contributions in the field of biotechnology. With a focus on developing unique therapeutic solutions, he has successfully secured one patent that enhances our understanding of neublastin and its implications in various assays.
Latest Patents
Ping Jin holds a patent for "Anti-neublastin antibodies and uses thereof." This invention discloses antibodies and antigen-binding fragments that specifically bind to neublastin polypeptides. The patent also details methods for utilizing these antibodies in assays to detect both endogenous and exogenous neublastin levels in biological samples. Moreover, it outlines innovative techniques for antagonizing the bioactivity of neublastin, potentially offering new avenues for therapeutic interventions.
Career Highlights
Currently, Ping Jin is affiliated with Gloriana Therapeutics Sarl, a company that focuses on advancing biotechnological research and therapies. His expertise in the field, combined with his innovative spirit, has made him a valuable asset to the organization. His research endeavors aim to bridge the gap between scientific discovery and practical therapeutic applications.
Collaborations
Throughout his career, Ping Jin has collaborated closely with colleagues, including Anthony Rossomando. This teamwork has fostered an environment of innovation, enabling the development of cutting-edge solutions that address complex medical challenges.
Conclusion
Ping Jin's dedication to advancing biotechnology and his patented work with anti-neublastin antibodies demonstrate his significant contributions to the field. As an inventor, he continues to play a pivotal role in enhancing our understanding of neublastin and its potential applications in medical science. His efforts at Gloriana Therapeutics Sarl, alongside talented coworkers, position him as a key figure in the landscape of innovative biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile